Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Malladi Drugs
AddedFeb 13, 2024
UpdatedJun 18, 2026
Malladi Drugs

Malladi Drugs

Malladi: Global manufacturer of active pharmaceutical ingredients for cough, cold, and therapeutic segments.

HQ
Carlstadt, NJ, US
Founded
1999
Overview
Compare
Fundraising
Employees

Malladi Drugs is a global manufacturer of active pharmaceutical ingredients, focusing on the cough and cold segment and therapeutic areas such as antihistamines, anticonvulsants, antidepressants, and anxiolytics. The company aims to provide high-quality pharmaceutical products to benefit society.

Malladi Drugs has established itself as a key player in the pharmaceutical industry, contributing significantly to global healthcare. Its commitment to quality and innovation has earned it a strong reputation and impact in the market.

Malladi Drugs - Similar Companies

Moksha8 logo

Moksha8

moksha8.com

Sun Pharmaceutical Industries logo

Sun Pharmaceutical Industries

Medison Pharma logo

Medison Pharma

medisonpharma.com

Dawah Pharmaceuticals logo

Dawah Pharmaceuticals

dawahpharma.com

Manhattan Pharmaceuticals logo

Manhattan Pharmaceuticals

Madeira Therapeutics logo

Madeira Therapeutics

Masters Pharmaceutical logo

Masters Pharmaceutical

mastersrx.com

Apothecary Products logo

Apothecary Products

Amerigen Pharmaceuticals logo

Amerigen Pharmaceuticals

amerigenpharma.com

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

Magna Pharmaceuticals logo

Magna Pharmaceuticals

magnaweb.com

Amneal Pharmaceuticals logo

Amneal Pharmaceuticals

amneal.com

Qilu Pharmaceutical Co. logo

Qilu Pharmaceutical Co.

Meitheal Pharmaceuticals logo

Meitheal Pharmaceuticals

meithealpharma.com

Kukje Pharma Co. logo

Kukje Pharma Co.

Malladi Drugs - Quick Facts

Who are Malladi Drugs' competitors?

Companies similar to Malladi Drugs include Moksha8, Sun Pharmaceutical Industries, Medison Pharma and Dawah Pharmaceuticals.

When was Malladi Drugs founded?

Malladi Drugs was founded in 1999.

Where is Malladi Drugs' headquarters located?

Malladi Drugs' headquarters is located in Carlstadt, NJ, US.

When was Malladi Drugs' last funding round?

Malladi Drugs' most recent funding round was for $2.5B (USD) in April 2022.

How much has Malladi Drugs raised to-date?

As of Apr 25, 2022, Malladi Drugs has raised a total of $2.5B (USD).

How many employees does Malladi Drugs have?

Malladi Drugs has 750 employees as of Feb 4, 2024.

Malladi Drugs - Classification

Ownership
  • Private
Geographic Exposure
  • Global
Model
  • Manufacturing
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Ingredients
  • Pharmaceuticals
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 12 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research